CRNC Stock Cash Flow Statements

Cerence Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Cerence Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31

cash flows from operating activities:
net income	-2,721,000	21,656,000	-24,288,000	-20,416,000	-313,543,000	-277,976,000	23,857,000	-11,552,000	-16,455,000	-26,089,000	-2,158,000	-230,127,000	-99,267,000	-476,000	19,044,000	7,991,000	5,798,000	10,466,000	21,638,000	6,817,000	-28,181,000	12,495,000	-11,762,000
adjustments to reconcile net income to net cash from operations:
depreciation and amortization	2,719,000	3,348,000	2,445,000	2,581,000	2,665,000	2,698,000	2,686,000	2,887,000	3,118,000	5,025,000	5,008,000	5,086,000	5,279,000	6,364,000	7,210,000	7,385,000	7,329,000	7,323,000	7,624,000	7,337,000	7,733,000	7,612,000	7,359,000
benefit from credit loss reserve	0			-79,000	-2,441,000			0	0				4,000	0	-418,000				-410,000
stock-based compensation	6,345,000	5,931,000	7,771,000	4,382,000	6,166,000	4,745,000	8,380,000	8,965,000	6,974,000	12,355,000	12,472,000	5,056,000	6,253,000	10,926,000	5,841,000	18,376,000	14,710,000	15,118,000	12,351,000	14,331,000	17,425,000	6,560,000	8,969,000
non-cash interest expense	1,299,000	1,487,000	1,861,000	1,579,000	1,542,000	1,471,000	1,468,000	1,464,000	540,000	466,000	444,000	1,359,000	1,327,000	1,294,000	1,301,000	1,283,000	1,276,000	1,224,000	1,230,000	1,261,000	1,379,000	1,314,000	1,332,000
gain on debt extinguishment			-327,000
deferred tax benefit	-1,032,000			-1,781,000				6,061,000	1,958,000	-258,000	-164,000			-707,000	-1,455,000	-607,000	3,841,000	6,453,000	-14,106,000		-7,957,000	313,000	-4,928,000
goodwill impairment				0	357,076,000
unrealized foreign currency transaction (gains) losses
other	0	0	-33,000	-31,000	-511,000	92,000	382,000	616,000	-3,396,000	5,372,000	-5,980,000	978,000	2,633,000	1,953,000	551,000	984,000	-109,000
changes in operating assets and liabilities:
accounts receivable	5,080,000	-16,829,000	8,800,000	15,522,000	-3,687,000	-5,008,000	4,933,000	-6,013,000	3,885,000	1,815,000	-16,651,000	15,036,000	-18,069,000	-11,112,000	7,555,000	7,449,000	6,508,000	-94,000	-8,112,000	12,259,000	30,545,000	-28,383,000	1,691,000
prepaid expenses and other assets	1,882,000	-1,951,000	27,201,000	-29,266,000	10,946,000	4,684,000	1,170,000	8,290,000	6,888,000	9,753,000	3,261,000	865,000	1,733,000	-16,647,000	-19,707,000	-13,596,000	-9,457,000	-8,633,000	1,025,000	-8,983,000	-7,723,000	4,588,000	-18,193,000
deferred costs	1,027,000	182,000	1,859,000	1,212,000	166,000	834,000	2,589,000	683,000	-48,000	973,000	1,586,000	901,000	857,000	1,387,000	1,509,000	1,906,000	1,243,000	1,784,000	2,051,000	-632,000	330,000	-887,000	-192,000
accounts payable	-1,008,000	-1,322,000	3,814,000	-6,322,000	-5,941,000	-2,674,000	2,382,000	975,000	-3,065,000	44,000	7,820,000	-4,481,000	-1,655,000	9,446,000	-3,153,000	505,000	7,035,000	-474,000	-3,655,000	-2,260,000	-6,554,000	5,479,000	905,000
accrued expenses and other liabilities	6,398,000	9,555,000	-33,087,000	31,110,000	-1,563,000	-5,385,000	3,712,000	-74,000	-3,264,000	3,185,000	-255,000	1,219,000	-583,000	682,000	-2,797,000	2,901,000	-1,056,000	-1,010,000	-1,960,000	8,536,000	6,255,000	-9,182,000	22,210,000
deferred revenue	6,765,000	4,258,000	6,107,000	9,585,000	5,034,000	7,001,000	-82,660,000	-3,092,000	-7,685,000	-3,251,000	-7,501,000	-8,459,000	-7,996,000	-1,512,000	-10,336,000	-11,253,000	-12,908,000	-14,625,000	-6,867,000	-13,851,000	-13,298,000	-10,546,000	2,065,000
net cash from operating activities	23,701,000	15,466,000	9,254,000	6,115,000	12,852,000	1,044,000	-2,815,000	11,258,000	-8,197,000	6,555,000	-2,118,000	-4,953,000	-3,928,000	1,598,000	5,145,000	23,321,000	24,059,000	16,200,000	10,809,000	26,212,000	19,312,000	-10,191,000	9,456,000
cash flows from investing activities:
capital expenditures	-7,650,000	-2,343,000	-1,360,000	-1,446,000	-774,000	-1,845,000	-931,000	-1,527,000	-1,520,000	-1,394,000	-683,000	-3,028,000	-4,433,000	-5,575,000	-4,410,000	-3,992,000	-2,874,000	-2,812,000	-2,369,000	-2,937,000	-5,930,000	-6,533,000	-3,612,000
free cash flows	16,051,000	13,123,000	7,894,000	4,669,000	12,078,000	-801,000	-3,746,000	9,731,000	-9,717,000	5,161,000	-2,801,000	-7,981,000	-8,361,000	-3,977,000	735,000	19,329,000	21,185,000	13,388,000	8,440,000	23,275,000	13,382,000	-16,724,000	5,844,000
sale and maturities of marketable securities	0	1,000,000	2,493,000	1,905,000	5,295,000	1,470,000	2,442,000	10,124,000	4,300,000	6,400,000	9,500,000	6,200,000	14,550,000	10,747,000	5,706,000	7,350,000
other investing activities	-429,000	-342,000	-374,000	-405,000	-441,000	-569,000	-322,000	-331,000	-472,000	-333,000	-219,000	284,000	469,000	707,000	559,000	398,000	438,000
net cash from investing activities	-8,079,000	-1,685,000	759,000	54,000	4,080,000	-944,000	1,189,000	8,266,000	-4,672,000	709,000	1,517,000	-7,148,000	2,548,000	-4,227,000	-1,738,000	-6,915,000	-20,869,000	-5,120,000	-8,727,000	-14,600,000	-5,930,000	-6,533,000	-3,612,000
cash flows from financing activities:
principal payments of short-term debt	-60,125,000	0	-26,964,000
common stock repurchases for tax withholdings for net settlement of equity awards	-29,000	-802,000	-1,369,000	-8,000	-113,000	-3,535,000	-6,209,000	-60,000	-404,000	-1,787,000	-2,643,000	-1,043,000	-1,537,000	-1,850,000	-44,573,000	-11,680,000	-1,889,000	-1,942,000	-30,258,000	-7,756,000	-694,000	-778,000	-141,000
payments for long-term debt issuance costs				0				-390,000	-16,383,000	0	-403,000					0	0	0	-520,000	-637,000	-5,250,000	0	-515,000
principal payment of lease liabilities arising from a finance lease	-102,000	-114,000	-115,000	-89,000	-101,000	-80,000	-122,000	-96,000	-39,000	-151,000	-165,000		-43,000	-91,000	-155,000		-88,000	-137,000	-101,000		-29,000	-12,000	-55,000
proceeds from the issuance of common stock	29,000	811,000	1,364,000	264,000	176,000	4,260,000	6,201,000	938,000	293,000	2,671,000	1,723,000	1,119,000	1,484,000	1,320,000	32,139,000	4,840,000	1,637,000	1,382,000	3,663,000
net cash from financing activities	-60,227,000	-105,000	-27,084,000	167,000	-457,000	645,000	-130,000	-4,308,000	4,417,000	-2,392,000	-3,051,000	-1,611,000	-1,659,000	-2,184,000	-14,152,000	-8,563,000	-1,903,000	-2,260,000	-28,779,000	-8,678,000	23,855,000	-1,024,000	107,400,000
effects of exchange rate changes on cash and cash equivalents	909,000	-411,000	-311,000	-373,000	-129,000	-305,000	-662,000	-162,000	-825,000	-152,000	-538,000	105,000	-326,000	-604,000	-447,000	-255,000	7,000	366,000	990,000	289,000	23,000	-64,000	152,000
net change in cash and cash equivalents	-43,696,000	13,265,000	-17,382,000	5,963,000	16,346,000	440,000	-2,418,000	15,054,000	-9,277,000	4,720,000	-4,190,000	-13,607,000	-3,365,000	-5,417,000	-11,192,000	7,588,000	1,294,000	9,186,000	-25,707,000	3,223,000	37,260,000	-17,812,000	113,396,000
cash and cash equivalents at beginning of period	0	0	121,485,000	0	0	0	101,154,000	0	0	0	94,847,000		0	0	128,428,000		0	0	136,067,000
cash and cash equivalents at end of period	-43,696,000	13,265,000	104,103,000	5,963,000	16,346,000	440,000	98,736,000	15,054,000	-9,277,000	4,720,000	90,657,000		-3,365,000	-5,417,000	117,236,000		1,294,000	9,186,000	110,360,000		37,260,000	-17,812,000	113,396,000
supplemental information:
cash paid for income taxes	1,634,000	3,096,000	9,000	2,130,000	1,794,000	3,152,000	3,104,000	5,433,000	1,699,000	1,594,000	2,459,000	2,405,000	3,274,000	4,139,000	2,455,000	4,231,000	500,000	883,000	563,000	1,250,000	304,000	-845,000	1,472,000
cash paid for interest	903,000	0	3,077,000	1,639,000	1,313,000	73,000	3,003,000	102,000	4,976,000	2,151,000	4,341,000	1,364,000	3,573,000	759,000	3,392,000	733,000	3,414,000	1,598,000	3,805,000	389,000	5,347,000	5,321,000	3,676,000
loss on debt extinguishment								0												0
unrealized foreign currency transaction losses		-1,652,000	1,997,000
benefit from expected credit loss reserve			207,000
deferred tax provision			4,927,000			10,651,000	30,298,000					-6,107,000
unrealized foreign currency transaction (gain) losses								2,048,000	1,020,000
purchases of marketable securities								0	-6,980,000	-3,964,000	-7,081,000	-10,604,000	-8,038,000	-9,522,000	-3,593,000	-8,671,000	-24,733,000	-2,709,000	-6,358,000
payments for equity investments													0				0
proceeds from revolving credit facility								0
payments of revolver credit facility
proceeds from long-term debt, net of discount								20,000,000												0	298,014,000	0	249,705,000
principal payments of long-term debt								0	-193,750,000	-3,125,000	-1,563,000	-1,561,000	-1,563,000	-1,563,000	-1,563,000	-1,563,000	-1,563,000	-1,563,000	-1,563,000	-1,563,000	-267,637,000
unrealized foreign currency transaction gains						1,750,000	-2,012,000
purchase of debt securities
(benefit from) benefit from credit loss reserve																-3,000	-151,000
payments for equity securities
net transactions with parent
distributions to parent
principal payments of lease liabilities arising from a finance leases
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
net transaction with parent																					-549,000	2,129,000	11,384,000
distribution to parent																					0	0	-152,978,000
maturities of marketable securities
benefit from doubtful accounts																				179,000	79,000
deferred tax (benefit) expense
changes in operating assets and liabilities, net of effects from acquisitions:
payments for business acquisitions, net of cash acquired
principal payments of lease liabilities arising from a finance lease
proceeds from issuance of common stock from employee stock plans
net advancement to parent

We provide you with 20 years of cash flow statements for Cerence stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Cerence stock. Explore the full financial landscape of Cerence stock with our expertly curated income statements.

The information provided in this report about Cerence stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.